Botanical species · safety record

Pilocarpus pennatifolius

The EFSA Compendium of Botanicals holds 2 constituent measurements and 1 adverse-effect record for Pilocarpus pennatifolius. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Pilocarpus pennatifolius Lem.

2Constituent measurements

1Safety records

2Cited sources

1Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 1 licensed products naming Pilocarpus pennatifolius as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Leaf

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Leaves	Solvent extraction	0.94 Percent	HPLC-MS/MS	Resolve DOI
Pilocarpine	Leaves	Solvent extraction	14.2 Percent	HPLC-MS/MS	Resolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	—	Leaves	Solvent extraction	—	In vitro	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Helena Frankland Sawaya, Alexandra Christine., Vaz, Boniek Gontijo., Eberlin, Marcos Nogueira., Mazzafera, Paulo. Screening species of Pilocarpus (Rutaceae) as sources of pilocarpine and other imidazole alkaloids . Genetic resources and crop evolution, 2011, vol. 58, no. 3, p. 471-480. DOI
Ferreres, Federico., Grosso, Clara., Gil-Izquierdo, Angel., Fernandes, Andreia., Valentao, Patricia., Andrade, Paula B. Comparing the phenolic profile of Pilocarpus pennatifolius Lem. by HPLC-DAD-ESI/MSn with respect to authentication and enzyme inhibition potential . Industrial crops and products, 2015, vol. 77, p. 391-401. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature